| |
|
|
|
Altimmune Inc  
|
|
12.23 1.71 (0.16%) |
11-30 16:00 |
|
Open: |
10.7 |
Pre close: |
10.52 |
Target:
|
14.89
|
|
High: |
12.53 |
Low: |
10.57 |
Resistance:
|
12.75
14.89
|
|
Volume: |
3,722,676 |
Market Cap: |
404M |
Support:
|
9.69
7.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.28
 |
MACD |
MACD(12,26):
|
-0.43 |
|
MA(20): |
10.34 |
Signal(12,26,9): |
-0.73 |
|
MA(100): |
16.82  |
Stochastic Oscillator |
%K(14,3):
|
67.79 |
|
MA(250): |
9.14 |
%D(3): |
49.06 |
|
Average Volume(K) |
3-Month: |
167910
|
52-Week |
High:
|
35.10 |
|
10-Days: |
163295 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
59.32 |
Change(%): |
473.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.090 |
Return on Equity (ttm) |
-34.1 |
Shares Out. (M) |
33.07 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-10.9 |
Shares Float (M) |
22.33 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.62 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
356.2 |
% Held by Institutions |
48.50 |
|
Forward EPS |
-1.600 |
Gross Profit (p.s.) |
-0.341 |
Shares Short (K) |
2910 |
|
Book Value (p.s.) |
6.070 |
EBITDA (p.s.) |
-0.758 |
P/E |
-5.89 |
|
Sales Per Share |
0.195 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.03 |
P/S |
63.17 |
|
Operating Margin |
-393.31 |
Levered Free Cash Flow
(M) |
-18.69 |
P/CF |
-17.69 |
|
|
|
|
|
|
